Inventor · disambiguated record
Kris Thielemans
Also filed as: THIELEMANS KRIS · THIELEMANS KRIS MARIA MAGDALENA
8 granted patents·9 pending applications·100 citations·filing 1998–2021
86Inventor score
Files withUNIV BRUSSEL VRIJE6LUDWIG INST CANCER RES4THIELEMANS KRIS MARIA MAGDALENA2MOSER MURIEL1UNIV BRUXELLES1
Top patents by PatentIndex Score
17 records- 0186US6291430B1Mage-3 peptides presented by HLA class II moleculesLUDWIG INST CANCER RES·Filed 1998·Granted Sep 18, 2001·48 cites·15 claims
- 0284US8476419B2Enhancing the T-cells stimulatory capacity of human antigen presenting cells and their use in vaccinationTHIELEMANS KRIS MARIA MAGDALENA·Filed 2008·Granted Jul 2, 2013·16 cites·9 claims
- 0383US6426217B1MAGE-3 peptides presented by HLA class II moleculesLUDWIG INST CANCER RES·Filed 2000·Granted Jul 30, 2002·17 cites·16 claims
- 0470US11684671B2Enhancing the T-cell stimulatory capacity of human antigen presenting cells in vitro and in vivo and its use in vaccinationUNIV BRUSSEL VRIJE·Filed 2019·Granted Jun 27, 2023·0 cites·8 claims
- 0568US7488793B2Isolated peptide which binds to HLA-Cw*07 and uses thereofLUDWIG INST CANCER RES·Filed 2004·Granted Feb 10, 2009·4 cites·4 claims
- 0665US9408909B2Enhancing the T-cell stimulatory capacity of human antigen presenting cells in vitro and in vivo and its use in vaccinationUNIV BRUSSEL VRIJE·Filed 2013·Granted Aug 9, 2016·0 cites·11 claims
- 0764US6716809B1Mage-A3 peptides presented by HLA class moleculesLUDWIG INST CANCER RES·Filed 1999·Granted Apr 6, 2004·15 cites·14 claims
- 0863US2018133311A1Enhancing the t-cell stimulatory capacity of human antigen presenting cells in vitro and in vivo and its use in vaccinationUNIV BRUSSEL VRIJE·Filed 2017·Application pending·0 cites
- 0960US7252825B2MAGE-3 peptides presented by HLA class II moleculesUNIV BRUXELLES·Filed 2002·Granted Aug 7, 2007·0 cites·13 claims
- 1059US2017000881A1Enhancing the t-cell stimulatory capacity of human antigen presenting cells in vitro and in vivo and its use in vaccinationUNIV BRUSSEL VRIJE·Filed 2016·Application pending·0 cites
- 1156US2009081127A1Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseMOSER MURIEL·Filed 2008·Application pending·0 cites
- 1253US2023097011A1A mixture of mrna to enhance the potency of dendritic cellsUNIV BRUSSEL VRIJE·Filed 2021·Application pending·0 cites
- 1348US2023126093A1Synthetic dna template for in vitro mrna transcriptionUNIV BRUSSEL VRIJE·Filed 2021·Application pending·0 cites
- 1447US2003118562A1Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseFiled 2002·Application pending·0 cites
- 1547US2003031656A1Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseFiled 2002·Application pending·0 cites
- 1646US2002141973A1Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor responseFiled 2001·Application pending·0 cites
- 1740US2013108663A1Enhancing the t-cell stimulatory capacity of human antigen presenting cells in vitro and in vivo and their use in vaccinationTHIELEMANS KRIS MARIA MAGDALENA·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kris Thielemans files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →